Literature DB >> 22891249

Post-aggregation oxidation of mutant huntingtin controls the interactions between aggregates.

Yasushi Mitomi1, Takao Nomura, Masaru Kurosawa, Nobuyuki Nukina, Yoshiaki Furukawa.   

Abstract

Aggregation of protein molecules is a pathological hallmark of many neurodegenerative diseases. Abnormal modifications have often been observed in the aggregated proteins, supporting the aggregation mechanism regulated by post-translational modifications on proteins. Modifications are in general assumed to occur in soluble proteins before aggregation, but actually it remains quite obscure when proteins are modified in the course of the aggregation. Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo. Copper ions as well as added hydrogen peroxide are found to oxidize the methionine residue, but notably, this oxidative modification occurs only in the aggregated HTT but not in the soluble state. Furthermore, the methionine oxidation creates additional interactions among HTT aggregates and alters overall morphologies of the aggregates. We thus reveal that protein aggregates can be a target of oxidative modifications and propose that such a "post-aggregation" modification is a relevant factor to regulate properties of protein aggregates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891249      PMCID: PMC3464579          DOI: 10.1074/jbc.M112.387035

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Experimental therapeutics in transgenic mouse models of Huntington's disease.

Authors:  M Flint Beal; Robert J Ferrante
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

2.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

3.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

4.  Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin.

Authors:  Tim E Williamson; Andreas Vitalis; Scott L Crick; Rohit V Pappu
Journal:  J Mol Biol       Date:  2009-12-21       Impact factor: 5.469

Review 5.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

6.  Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I.

Authors:  Yuan Qi Wong; Katrina J Binger; Geoffrey J Howlett; Michael D W Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

Review 7.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

8.  Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.

Authors:  Xiaofeng Gu; Erin R Greiner; Rakesh Mishra; Ravindra Kodali; Alex Osmand; Steven Finkbeiner; Joan S Steffan; Leslie Michels Thompson; Ronald Wetzel; X William Yang
Journal:  Neuron       Date:  2009-12-24       Impact factor: 17.173

9.  SUMO modification of Huntingtin and Huntington's disease pathology.

Authors:  Joan S Steffan; Namita Agrawal; Judit Pallos; Erica Rockabrand; Lloyd C Trotman; Natalia Slepko; Katalin Illes; Tamas Lukacsovich; Ya-Zhen Zhu; Elena Cattaneo; Pier Paolo Pandolfi; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

10.  The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation.

Authors:  Stephen Tam; Christoph Spiess; William Auyeung; Lukasz Joachimiak; Bryan Chen; Michelle A Poirier; Judith Frydman
Journal:  Nat Struct Mol Biol       Date:  2009-11-15       Impact factor: 15.369

View more
  11 in total

Review 1.  Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.

Authors:  C Y Daniel Lee; Jeffrey P Cantle; X William Yang
Journal:  FEBS J       Date:  2013-07-31       Impact factor: 5.542

2.  Huntingtin N-Terminal Monomeric and Multimeric Structures Destabilized by Covalent Modification of Heteroatomic Residues.

Authors:  James R Arndt; Samaneh Ghassabi Kondalaji; Megan M Maurer; Arlo Parker; Justin Legleiter; Stephen J Valentine
Journal:  Biochemistry       Date:  2015-07-07       Impact factor: 3.162

3.  Oxidation Promotes Distinct Huntingtin Aggregates in the Presence and Absence of Membranes.

Authors:  Adewale Adegbuyiro; Alyssa R Stonebraker; Faezeh Sedighi; Caleb K Fan; Breanna Hodges; Peng Li; Stephen J Valentine; Justin Legleiter
Journal:  Biochemistry       Date:  2022-06-27       Impact factor: 3.321

4.  Interaction of Huntingtin Exon-1 Peptides with Lipid-Based Micellar Nanoparticles Probed by Solution NMR and Q-Band Pulsed EPR.

Authors:  Alberto Ceccon; Thomas Schmidt; Vitali Tugarinov; Samuel A Kotler; Charles D Schwieters; G Marius Clore
Journal:  J Am Chem Soc       Date:  2018-05-14       Impact factor: 15.419

5.  Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.

Authors:  Laura F DiGiovanni; Andrew J Mocle; Jianrun Xia; Ray Truant
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

6.  Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Andre L Samson; Anja S Knaupp; Itamar Kass; Oded Kleifeld; Emilia M Marijanovic; Victoria A Hughes; Chris J Lupton; Ashley M Buckle; Stephen P Bottomley; Robert L Medcalf
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

Review 7.  Oxidative stress and neurodegenerative disorders.

Authors:  Jie Li; Wuliji O; Wei Li; Zhi-Gang Jiang; Hossein A Ghanbari
Journal:  Int J Mol Sci       Date:  2013-12-16       Impact factor: 5.923

8.  Screening of Drugs Inhibiting In vitro Oligomerization of Cu/Zn-Superoxide Dismutase with a Mutation Causing Amyotrophic Lateral Sclerosis.

Authors:  Itsuki Anzai; Keisuke Toichi; Eiichi Tokuda; Atsushi Mukaiyama; Shuji Akiyama; Yoshiaki Furukawa
Journal:  Front Mol Biosci       Date:  2016-08-09

9.  Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy.

Authors:  Eva Cabet; Sabrina Batonnet-Pichon; Florence Delort; Blandine Gausserès; Patrick Vicart; Alain Lilienbaum
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

Review 10.  Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.

Authors:  Amit Kumar; Rajiv R Ratan
Journal:  J Huntingtons Dis       Date:  2016-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.